François Lebreton

3.4k total citations · 1 hit paper
58 papers, 2.1k citations indexed

About

François Lebreton is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, François Lebreton has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Medicine, 26 papers in Molecular Biology and 22 papers in Infectious Diseases. Recurrent topics in François Lebreton's work include Antibiotic Resistance in Bacteria (31 papers), Antimicrobial Resistance in Staphylococcus (20 papers) and Bacterial biofilms and quorum sensing (12 papers). François Lebreton is often cited by papers focused on Antibiotic Resistance in Bacteria (31 papers), Antimicrobial Resistance in Staphylococcus (20 papers) and Bacterial biofilms and quorum sensing (12 papers). François Lebreton collaborates with scholars based in United States, Ukraine and Brazil. François Lebreton's co-authors include Michael S. Gilmore, Willem van Schaik, Rob J. L. Willems, Ashlee M. Earl, Abigail L. Manson, Patrick McGann, José T. Saavedra, Timothy J. Straub, Vincent Cattoir and Roland Leclercq and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

François Lebreton

51 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differentiation of hypervirulent and classical Klebsiella pneumoniae with acquired drug resistance

2024 52 citations Melissa J. Martin, Brendan W. Corey et al. mBio profile →

Peers

Countries citing papers authored by François Lebreton

Since Specialization

Citations

This map shows the geographic impact of François Lebreton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Lebreton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Lebreton more than expected).

Fields of papers citing papers by François Lebreton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Lebreton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Lebreton. The network helps show where François Lebreton may publish in the future.

Co-authorship network of co-authors of François Lebreton

This figure shows the co-authorship network connecting the top 25 collaborators of François Lebreton. A scholar is included among the top collaborators of François Lebreton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Lebreton. François Lebreton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unveiling a hidden threat: whole genome sequencing exposes the cross-hospital spread of extensively drug-resistant Pseudomonas aeruginosa 2026 ·Frontiers in Microbiology ·(unknown), Brendan T. Jones, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), François Lebreton, (unknown)	0
2	An open-source nanopore-only sequencing workflow for analysis of clonal outbreaks delivers short-read level accuracy 2025 ·Journal of Clinical Microbiology ·Nick Vereecke, (unknown), (unknown), Brendan W. Corey, François Lebreton, Patrick McGann, John P. Dekker	2
3	Distribution and expression of the aac(6′)-Im (aacA16) aminoglycoside resistance gene 2024 ·Journal of Antimicrobial Chemotherapy ·Christopher J. Harmer, (unknown), François Lebreton, Paphavee Lertsethtakarn, Patrick McGann, Ruth M. Hall	1
4	Detection of carbapenemase producing Acinetobacter baumannii ST19 from Georgia and Ukraine carrying blaOXA-23, blaOXA-72, and/or blaNDM-5, December 2019 to June 2023 2024 ·Eurosurveillance ·Ting Luo, Melissa J. Martin, (unknown), (unknown), Nino Trapaidze, (unknown), Christine Hulseberg, (unknown), Yoon I. Kwak, Rosslyn Maybank, Thomas Musich, (unknown), Jason W. Bennett, Patrick McGann, François Lebreton	7
5	Molecular Surveillance of Multidrug-Resistant Bacteria among Refugees from Afghanistan in 2 US Military Hospitals during Operation Allies Refuge, 2021 2024 ·Emerging infectious diseases ·Cole Anderson, François Lebreton, (unknown), Brendan T. Jones, Melissa J. Martin, Hunter Jackson Smith, Roseanne Ressner, Sara Robinson, (unknown), (unknown), Michael G. Backlund, (unknown), (unknown), (unknown), (unknown), Patrick McGann, Jason W. Bennett	3
6	A panel of diverse Klebsiella pneumoniae clinical isolates for research and development 2023 ·Microbial Genomics ·Melissa J. Martin, (unknown), Ana Ong, Rosslyn Maybank, Yoon I. Kwak, (unknown), (unknown), (unknown), (unknown), Anthony R. Jones, Mary Hinkle, Paige Waterman, Emil Lesho, François Lebreton, Jason W. Bennett, Patrick McGann	17
7	The Emergence and Persistence ofCandida aurisin Western New York With No Epidemiologic Links: A Failure of Stewardship? 2023 ·Open Forum Infectious Diseases ·Patrick McGann, François Lebreton, (unknown), Jason Stam, Rosslyn Maybank, (unknown), Melissa Bronstein, Jason W. Bennett, Emil Lesho	2
8	Identification of an Outbreak Cluster of Extensively Antibiotic-Resistant GC1 Acinetobacter baumannii Isolates in U.S. Military Treatment Facilities 2023 ·Microbiology Spectrum ·(unknown), Christopher J. Harmer, François Lebreton, Jason Stam, Jason W. Bennett, Ruth M. Hall, Patrick McGann	4
9	Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistance 2022 ·Journal of Antimicrobial Chemotherapy ·Christopher J. Harmer, François Lebreton, Jason Stam, Patrick McGann, Ruth M. Hall	9
10	Mechanisms of IS 26 -Mediated Amplification of the aphA1 Gene Leading to Tobramycin Resistance in an Acinetobacter baumannii Isolate 2022 ·Microbiology Spectrum ·Christopher J. Harmer, François Lebreton, Jason Stam, Patrick McGann, Ruth M. Hall	22
11	A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development 2021 ·JAC-Antimicrobial Resistance ·François Lebreton, Erik Snesrud, (unknown), Emma G. Mills, Madeline R. Galac, Jason Stam, Ana Ong, Rosslyn Maybank, Yoon I. Kwak, (unknown), (unknown), Melissa Ly, (unknown), Paige Waterman, Mary Hinkle, Anthony R. Jones, Emil Lesho, Jason W. Bennett, Patrick McGann	29
12	Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York 2021 ·Clinical Infectious Diseases ·Emil Lesho, Brendan W. Corey, François Lebreton, Ana Ong, (unknown), Jason W. Bennett, Edward E. Walsh, Patrick McGann	3
13	Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis 2021 ·Nature Cancer ·Noriho Iida, Eishiro Mizukoshi, Tatsuya Yamashita, Masahiro Yutani, Jun Seishima, Ziyu Wang, Kuniaki Arai, Hikari Okada, Taro Yamashita, Yoshio Sakai, Yusuke Masuo, Rina Agustina, Yukio Kato, Yukako Fujinaga, Masanobu Oshima, Masao Honda, François Lebreton, Michael S. Gilmore, Shuichi Kaneko	55
14	Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil 2020 ·Antimicrobial Agents and Chemotherapy ·Lara Mendes de Almeida, François Lebreton, Anthony O. Gaca, Paulo J. M. Bispo, José T. Saavedra, (unknown), Luciano Aparecido Meireles Grillo, Ticiano Gomes do Nascimento, (unknown), Andréa Micke Moreno, Michael S. Gilmore	21
15	Coexistence of the oxazolidinone resistance–associated genes cfr and optrA in Enterococcus faecalis from a healthy piglet in Brazil 2020 ·Frontiers in Marine Science ·Lara Mendes de Almeida, Anthony O. Gaca, Paulo J. M. Bispo, François Lebreton, José T. Saavedra, (unknown), Irinaldo Diniz Basílio Júnior, (unknown), (unknown), Andréa Micke Moreno, Michael S. Gilmore	1
16	Identification of a Functionally Unique Family of Penicillin-Binding Proteins 2017 ·Journal of the American Chemical Society ·Michael A. Welsh, Atsushi Taguchi, Kaitlin Schaefer, Daria Van Tyne, François Lebreton, Michael S. Gilmore, Daniel Kahne, Suzanne Walker	53
17	Characterization of Multi-Drug Resistant Enterococcus faecalis Isolated from Cephalic Recording Chambers in Research Macaques (Macaca spp.) 2017 ·PLoS ONE ·(unknown), (unknown), François Lebreton, (unknown), César de la Fuente‐Núñez, (unknown), Michael S. Gilmore, James G. Fox	18
18	Enterococcus Diversity, Origins in Nature, and Gut Colonization 2014 ·Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy ·François Lebreton, Rob J. L. Willems, Michael S. Gilmore	155
19	Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal Strains 2013 ·mBio ·François Lebreton, Willem van Schaik, Abigail L. Manson, Paul A. Godfrey, Allison Griggs, Varun Mazumdar, Jukka Corander, Lu Cheng, Sakina Saif, Sarah Young, Qiandong Zeng, Jennifer R. Wortman, Bruce Birren, Rob J. L. Willems, Ashlee M. Earl, Michael S. Gilmore	314
20	Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era 2013 ·Current Opinion in Microbiology ·Michael S. Gilmore, François Lebreton, Willem van Schaik	202

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact